‘AI All-Star’ Microsoft’s rosy earnings spark rally in tech stocks

By Nivedita Balu and Aditya Soni (Reuters) – Microsoft Corp shares surged about 7% on Wednesday and lifted tech stocks after the company’s robust earnings eased fears of a slowdown in cloud computing and boosted confidence that artificial intelligence will become a major growth driver. The Redmond, Washington-based tech giant is set to add about…

Read More

German government slightly raises 2023 GDP forecast

BERLIN (Reuters) -The German government has raised its economic growth forecast for this year to 0.4% from a previously predicted 0.2%, according to its spring economic projections published on Wednesday and first reported by Reuters last week. “A gradual recovery is underway, despite a persistently difficult environment,” German Economy Minister Robert Habeck said. He expects…

Read More

EU countries should focus on net expenditure, cut debt over 4 years -EU executive

By Jan Strupczewski BRUSSELS (Reuters) -The European Commission proposed on Wednesday that, under a reform of the EU’s fiscal rules, governments should ensure public debt falls by an individually negotiated amount over four years and stays on a downward path for a decade afterwards. The proposal, which sets no numerical target for how much the…

Read More

Canada’s Rogers beats profit estimates on wireless business strength

(Reuters) -Rogers Communications Inc reported a better-than-expected quarterly profit on Wednesday, as gains in its wireless business helped offset weakness in its cable TV unit. Demand for Rogers’ 5G services has remained high, but increased cord-cutting hurt its cable business. The telecom giant’s wireless revenue grew 10% in the first quarter. Cable revenue fell 2%….

Read More

Roche Q1 sales decline tempered by swift uptake of new eye drug

By Ludwig Burger (Reuters) -Switzerland’s Roche said first-quarter sales dropped 7% on falling demand for its COVID-19 therapies and tests, less steep than analysts had expected thanks to strong revenue growth from a new eye drug. Group revenue fell to 15.3 billion Swiss francs ($17.2 billion), the company reported on Wednesday, beating a market view…

Read More